Biogen Inc.
BIIB
$247.13-4.28 (1.70%)Nov 19
After-hours: $242.00 (-2.08%)
Biogen Inc. (BIIB)
$247.13-4.28-1.70%Nov 19
Loading chart…
USA›Health Care›Biotechnology›Biotechnology
YTD40%
M.cap.36.5 bn
Std.Dev, 1y2.07
Vol, bn0.3 (med)
RSI43
P/E20.4
MFI24 (oversold)
P/S3.54
ADX19 (no trend)
P/B1.93
Beta0.10
Div—
Debt/EBITDA2.67
Payout—
Price target
Buy 19 (73%)Hold 6 (23%)Sell 1 (4%)
Next earnings5 Feb, before open
Earnings surprise
Short interest3.7% (-0.0%), 30 Oct 2026
Fund owners #905 (-186)
Insider ownership$122 mm
Insider sellingVery Low
Insider buying—
General
M.Cap$36.5B
Dividends—
Next report5 Feb, before open
Forecast
Valuation
Target
P/E20.4
P/S3.54
P/B1.93
Fundamentals
5-y avg sales growth-6.0%
Debt / EBITDA2.67
ROE7.1%
Altman Z-score3.20 (safe)
Technicals
RSI43
MFI24
Price / MA50+4.6% (high) ↓
Trend pattern
Financial Statements
No data available
Financial Statements
No data available
Team
Loading…
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Investor Presentations
Loading…
Options
Exp. from:to:
Strike from:to:
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
Stress Test
Loading…
About

Biogen Inc. is a pharmaceutical company that specializes in discovering, developing, and manufacturing therapies for neurological and neurodegenerative diseases. Its products treat multiple sclerosis, Alzheimer’s disease, spinal muscular atrophy, and other conditions. The company also collaborates with several pharmaceutical firms and has been in operation since 1978.

WikipediaHeadcount: 7,500
Address:225 Binney Street, Cambridge, MA, United States, 02142
About

Biogen Inc. is a pharmaceutical company that specializes in discovering, developing, and manufacturing therapies for neurological and neurodegenerative diseases. Its products treat multiple sclerosis, Alzheimer’s disease, spinal muscular atrophy, and other conditions. The company also collaborates with several pharmaceutical firms and has been in operation since 1978.

https://www.biogen.com
Beta 0.10